Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

NELL-1: role and mechanisms in disease pathogenesis and development

Mi F., Yue Q., Deng X., Jian L., Wu Y.

Narrative Review on Chronic Kidney Disease, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Cell Dev Biol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42099386
PMCID
PMC13144030
DOI
10.3389/fcell.2026.1783756

Abstract (original English)

NELL-1 (NEL-like protein 1) is a multifunctional secreted glycoprotein that has been implicated in a variety of biological processes, including skeletal development, immune regulation, and tumorigenesis. Despite its significance, the regulatory mechanisms of NELL-1 across different tissues, the diversity of its signaling pathways, and its context-dependent roles in disease are not fully elucidated. This gap in understanding hinders the systematic development and clinical translation of potential applications. Current research suggests that NELL-1 influences skeletal development and regeneration through pathways such as Wnt/β-catenin, MAPK, and Runx3-Indian hedgehog (Ihh). Additionally, it plays crucial roles in conditions such as membranous nephropathy, various tumors, and neurodevelopmental disorders. The distinct isoforms of NELL-1, such as NELL-1 570 and NELL-1-ΔE, exhibit specific functional properties and hold significant therapeutic promise, particularly in bone regeneration and tumor suppression. This review aims to provide a comprehensive analysis of the molecular mechanisms of NELL-1 in osteogenesis, chondrogenesis, immune regulation, and tumor suppression. It also explores various strategies to enhance its stability and targeting, including PEG modification and nanoparticle delivery systems. In conclusion, NELL-1 represents a key molecule with multi-tissue, multi-dise

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research